NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
BIGG DIGITAL ASSETS INC
BBKCF
BIT Mining
BTCM
Coinbase
COIN
US Stock MarketDetailed Quotes
XTLB XTL Biopharmaceuticals
- 1.910
- +0.060+3.24%
Trading Dec 3 13:54 ET
10.41MMarket Cap-61612P/E (TTM)
1.910High1.810Low9.38KVolume1.775Open1.850Pre Close17.49KTurnover0.23%Turnover RatioLossP/E (Static)5.45MShares4.99052wk High3.85P/B7.89MFloat Cap0.76052wk Low--Dividend TTM4.13MShs Float600.000Historical High--Div YieldTTM5.41%Amplitude0.625Historical Low1.865Avg Price1Lot Size
XTL Biopharmaceuticals Key Stats
EPS
According to the latest financial report of XTL Biopharmaceuticals, the latest earnings per share (TTM) for the company is 0.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about XTL Biopharmaceuticals's free cash flow? The latest report shows it as -508.00K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of XTL Biopharmaceuticals shows that the company's current ratio is 11.43, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of XTL Biopharmaceuticals, the quick ratio is 11.16, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of XTL Biopharmaceuticals? The latest ROE figure is 19.70%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of XTL Biopharmaceuticals, the total asset return on investment (ROA) is 18.12%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check XTL Biopharmaceuticals's latest financial report to see how their gross margin is doing - currently at 61.95%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of XTL Biopharmaceuticals, the net profit margin is 109.29%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.